LGALS3 and pneumococcal infection: Farnworth et al. (2008) [25] suggested that the GAL-3 increased activity could enhance the inflammatory response, since it promotes neutrophil longevity or its bacteriostatic activity, improving clinical outcomes after severe pneumococcal infection.